Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Lap Bands May Result in More Complications Than Weight Loss
Bloomberg
Tuesday, March 22, 2011 - 9:22am
tags:
obesity, Lap-Band, Allergan
Merck, Sanofi Abandon Plan to Combine Animal Health Units
Bloomberg
Tuesday, March 22, 2011 - 7:29am
tags:
animal health, M&A, Merck, Sanofi
Bristol reports positive results for melanoma drug
Yahoo/AP
Tuesday, March 22, 2011 - 7:27am
tags:
Bristol-Myers Squibb, skin cancer, melanoma, ipilimumab
J&J Duped South Carolina Doctors Over Risperdal, Lawyer Says
Bloomberg
Tuesday, March 22, 2011 - 7:26am
tags:
South Carolina, JNJ, Risperdal, Ortho-McNeil-Janssen, antipsychotics
Nektar starts trial on next-generation opioid
Bizjournals.com
Tuesday, March 22, 2011 - 7:24am
tags:
opiods, Nektar, painkillers, NKTR-181
See No Evil: How Too-Detailed Expense Reports Allegedly Got an Amgen Sales Rep Fired
BNET Pharma
Monday, March 21, 2011 - 2:57pm
tags:
Amgen, drug reps, Aranesp, whistleblowers
Comparing Medivation, Inc.'s and Johnson & Johnson's Prostate Cancer Drugs
Seeking Alpha
Monday, March 21, 2011 - 2:56pm
tags:
prostate cancer, Medivation, JNJ, Pfizer, Astellas, MDV3100, abiraterone
Venture backers inject $25M into Synageva's rare disease platform
Fierce Biotech
Monday, March 21, 2011 - 1:40pm
tags:
venture capital, Synageva, Lysosomal Acid Lipase deficiency
The Genzyme Corporation: Under Pressure for a Lack of Production
Intellectual Property Brief
Monday, March 21, 2011 - 1:37pm
tags:
Genzyme, patents, Fabrazyme, Fabry's disease
Big Pharma executive compensation plans 'flawed' - study
Pharma Times, UK
Monday, March 21, 2011 - 11:58am
tags:
Big Pharma, executive pay
Andrew Witty of GSK: 'Big firms have allowed themselves to be seen as detached from society'
Guardian, UK
Monday, March 21, 2011 - 11:56am
tags:
UK, GSK, Andrew Witty, Pharma CEOs
Mylan Sues U.S. FDA to Block Ranbaxy’s Sale of Lipitor
Bloomberg
Monday, March 21, 2011 - 11:43am
tags:
Mylan, Ranbaxy, FDA, Lipitor, generics
J&J CEO Bill Weldon Has ‘No Plans’ To Retire Now
Pharmalot
Monday, March 21, 2011 - 11:41am
tags:
Pharma CEOs, William Weldon, JNJ
DSM Likely Interested in Pfizer Nutrition Unit, Cheuvreux Says
Bloomberg
Monday, March 21, 2011 - 11:35am
tags:
Royal DSM, Pfizer, M&A
Shire advances rival to Dyax drug
Bizjournals.com
Monday, March 21, 2011 - 11:34am
tags:
Shire, Dyax, hereditary angiodema, Kalbitor, Firazyr
XenoPort announces mid-stage drug study result
Yahoo/AP
Monday, March 21, 2011 - 11:32am
tags:
XenoPort, arbaclofen placarbil, heartburn
Why InterMune's Earnings Aren't So Hot
Motley Fool
Monday, March 21, 2011 - 11:31am
tags:
earnings, InterMune
Roche, Curis Skin Cancer Drug Advances
TheStreet.com
Monday, March 21, 2011 - 11:25am
tags:
skin cancer, Roche, Curis
Ariad Pharmaceuticals: Solid Company but Not a Steal
Seeking Alpha
Monday, March 21, 2011 - 11:24am
tags:
Ariad Pharmaceuticals
Depomed's Recent Events Boost Balance Sheet
Seeking Alpha
Monday, March 21, 2011 - 11:21am
tags:
Depomed, Abbott Laboratories, Gralise, Glumetza

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.